SARC024

Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). SARC024 sites include: • Atrium Health Levine Cancer Institute (Atlanta, GA)• …

Read more
Jonathan Fletcher

SARC appoints Chief Scientific Officer

SARC is pleased to announce that Dr. Jonathan Fletcher has been appointed Chief Scientific Officer. Dr. Fletcher is a lab-based medical and pediatric oncologist at Harvard Medical School, Brigham and Women’s …

Read more

July is Sarcoma Awareness Month

SARC collaborator SFA is hosting a virtual Advocacy Day on July 21, 2021, during Sarcoma Awareness Month. If you would like to be a part of this day, or to learn …

Read more

JUNE 4, 2021 SARC SEMIANNUAL MEETING

Thank you for attending the 2021 SARC Semiannual Virtual Meeting on June 4, 2021. If you were not able to join the virtual event please view the agenda along with …

Read more
Steven W. Young

Message from SARC President & CEO

“I’d like to share an abridged view into some of SARC’s present and future research initiatives and strategic planning to evolve SARC’s collaborative model for even greater impact…Among the areas …

Read more
Rare Disease Day logo

Sarcoma at NIH 2021 Rare Disease Day

Sarcoma was highlighted during 2021 Rare Disease Day at the National Institute for Health (NIH). Dr. Francis Collins, NIH Director noted “We’ve made real progress in these 10 years, first …

Read more
Brigitte Widemann

Congratulations to Brigitte Widemann, MD

Congratulations to Brigitte Widemann, MD, for being named a Top Ten Clinical Research Achievement Awardee by the Clinical Research Forum and receiving a Distinguished Clinical Research Achievement Award for her …

Read more